Bionano Genomics to Report Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call and Webcast on March 1st, 2022

Rhea-AI Summary

Bionano Genomics (BNGO) will host a conference call on March 1, 2022, at 4:30 p.m. ET to discuss its fourth quarter and year-end 2021 financial results and share recent corporate developments. The call can be accessed via toll-free and international dial-ins, with a conference ID of 8795841. An archived version of the webcast will be available in the Investors section of the company's website. Bionano focuses on genome analysis, providing solutions and diagnostic services for biology and medicine.

SAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 1^st, 2022 at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2021 and to highlight recent corporate progress.

Conference Call & Webcast Details

Date:	Tuesday, March 1st, 2022
Time:	4:30 p.m. Eastern Time
Toll Free:	1-855-940-5312
Toll/International:	1-929-517-0416
Conference ID:	8795841
Webcast:	https://edge.media-server.com/mmc/p/iy5k7mh6

To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay in the Investors section of the Bionano website.

About Bionano Genomics

Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, the Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit bionanogenomics.com, lineagen.com or biodiscovery.com

CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com

Investor Relations and
Media Contact:
Amy Conrad
Juniper Point
+1 (858) 366-3243
amy@juniper-point.com

FAQ

When is Bionano Genomics' next earnings call?

Bionano Genomics will host its next earnings call on March 1, 2022, at 4:30 p.m. ET.

What will Bionano Genomics discuss in the March 1 earnings call?

The company will report its fourth quarter and year-end 2021 financial results and highlight recent corporate progress during the call.

How can I access the Bionano Genomics earnings call?

Participants can access the call by dialing the toll-free number 1-855-940-5312 or the international number 1-929-517-0416.

Is there a webcast for the Bionano Genomics conference call?

Yes, the conference call will be available via a live webcast, which can be accessed on Bionano Genomics' website.